Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 16, Pages 8885
Publisher
MDPI AG
Online
2021-08-18
DOI
10.3390/ijms22168885
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum Extracellular Vesicle-Derived miRNAs in Patients with Non-Small Cell Lung Cancer—Search for Non-Invasive Diagnostic Biomarkers
- (2021) Jolanta Kryczka et al. Diagnostics
- CDKN1A upregulation and cisplatin‑pemetrexed resistance in non‑small cell lung cancer cells
- (2020) Alice Zamagni et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MiR-200b Inhibits Tumor Growth and Chemoresistance via Targeting p70S6K1 in Lung Cancer
- (2020) Hui-Fang Jin et al. Frontiers in Oncology
- MicroRNA ‐92b acts as an oncogene by targeting PTEN / AKT in NSCLC
- (2020) Jia‐Hui Guo et al. CELL BIOCHEMISTRY AND FUNCTION
- Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
- (2020) Milad Ashrafizadeh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Janus Face of p53-Targeting Ubiquitin Ligases
- (2020) Qian Hao et al. Cells
- Annexin A1 is a potential biomarker of bone metastasis in small cell lung cancer
- (2020) Peng Chen et al. Oncology Letters
- Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway
- (2019) Wen-Chien Huang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Interaction of tumor-associated macrophages and cancer chemotherapy
- (2019) Irina Larionova et al. OncoImmunology
- p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signaling
- (2019) Yize Zhang et al. Cancer Cell International
- Resistance mechanisms and potent-targeted therapies of ROS1-positive lung cancer
- (2019) Annie Roys et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MicroRNAs as Potential Biomarkers for Chemoresistance in Adenocarcinomas of the Esophagogastric Junction
- (2019) Christina Just et al. Journal of Oncology
- New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment
- (2019) Shang-Hung Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MDIG promotes cisplatin resistance of lung adenocarcinoma by regulating ABC transporter expression via activation of the WNT/β‑catenin signaling pathway
- (2019) Qing Wang et al. Oncology Letters
- PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around
- (2019) Anastasios Gkountakos et al. Cancers
- Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer
- (2019) Ludovic Fournel et al. CANCER LETTERS
- Genetic polymorphism of miRNA-196a and its target gene annexin-A1 expression based on ethnicity in Pakistani female breast cancer patients
- (2019) Amena Rahim et al. Pakistan Journal of Medical Sciences
- The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism
- (2019) Karolien Vanhove et al. Frontiers in Oncology
- Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis
- (2019) Wan Liu et al. CANCER LETTERS
- A Strong Decrease in TIMP3 Expression Mediated by the Presence of miR-17 and 20a Enables Extracellular Matrix Remodeling in the NSCLC Lesion Surroundings
- (2019) Karolina H. Czarnecka et al. Frontiers in Oncology
- Cell Migration Related to MDR—Another Impediment to Effective Chemotherapy?
- (2018) et al. MOLECULES
- Multiple primary lung cancer: A literature review
- (2018) Anna Romaszko et al. Advances in Clinical and Experimental Medicine
- MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2
- (2018) Ming-Jenn Chen et al. Oncotarget
- Exosome-mediated breast cancer chemoresistance via miR-155 transfer
- (2018) Juliana Carvalho Santos et al. Scientific Reports
- A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop
- (2018) De-Wei Wu et al. Theranostics
- miRNA‑328 overexpression confers cisplatin resistance in non‑small cell lung cancer via targeting of PTEN
- (2018) Chunmei Wang et al. Molecular Medicine Reports
- Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?
- (2018) Venus Sosa Iglesias et al. Frontiers in Oncology
- The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications
- (2018) Wanyin Lim et al. QUANTITATIVE IMAGING IN MEDICINE AND SURGERY
- PTEN inhibits non‑small cell lung cancer cell growth by promoting G0/G1 arrest and cell apoptosis
- (2018) Libao Liu et al. Oncology Letters
- The Role of Blm Helicase in Homologous Recombination, Gene Conversion Tract Length, and Recombination Between Diverged Sequences inDrosophilamelanogaster
- (2017) Henry A. Ertl et al. GENETICS
- Drug Resistance Driven by Cancer Stem Cells and Their Niche
- (2017) Marta Prieto-Vila et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest
- (2017) Navin Sarin et al. PLoS One
- Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer
- (2017) Precious Takondwa Makondi et al. PLoS One
- Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy
- (2017) Lais Osmani et al. SEMINARS IN CANCER BIOLOGY
- Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer
- (2017) Gen Lin et al. Oncotarget
- MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
- (2017) Irina Fadejeva et al. Oncotarget
- Progress and prospects of early detection in lung cancer
- (2017) Sean Blandin Knight et al. Open Biology
- The Role of Blm Helicase in Homologous Recombination, Gene Conversion Tract Length, and Recombination Between Diverged Sequences inDrosophilamelanogaster
- (2017) Henry A. Ertl et al. GENETICS
- RAD18 polymorphisms are associated with platinum-based chemotherapy toxicity in Chinese patients with non-small cell lung cancer
- (2016) Tian-qing Chu et al. ACTA PHARMACOLOGICA SINICA
- The Warburg effect and drug resistance
- (2016) Bhaskar Bhattacharya et al. BRITISH JOURNAL OF PHARMACOLOGY
- Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy
- (2016) Panpan Zhang et al. CANCER SCIENCE
- Can the response to a platinum-based therapy be predicted by the DNA repair status in non-small cell lung cancer?
- (2016) Marianna Macerelli et al. CANCER TREATMENT REVIEWS
- Correlation between PD-L1 expression and outcome of NSCLC patients treated with anti-PD-1/PD-L1 agents: A meta-analysis
- (2016) Omar Abdel-Rahman CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Exploring miRNA based approaches in cancer diagnostics and therapeutics
- (2016) Shivangi Mishra et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Downregulation of microRNA-196a enhances the sensitivity of non-small cell lung cancer cells to cisplatin treatment
- (2016) QIAN LI et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Prognostic and Predictive Effect of TP53 Mutations in Patients with Non–Small Cell Lung Cancer from Adjuvant Cisplatin–Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis
- (2016) Xiaoli Ma et al. Journal of Thoracic Oncology
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells
- (2016) Ping Chen et al. CELLULAR ONCOLOGY
- miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET
- (2016) Qing-yong Chen et al. Oncotarget
- PTEN expression is a prognostic marker for patients with non-small cell lung cancer: a systematic review and meta-analysis of the literature
- (2016) Jian Xiao et al. Oncotarget
- Partners in the Warburg effect
- (2016) Joshua D Rabinowitz et al. eLife
- DNA damage repair and tolerance: a role in chemotherapeutic drug resistance
- (2016) M. R. Salehan et al. BRITISH JOURNAL OF BIOMEDICAL SCIENCE
- miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells
- (2015) Z Zhao et al. CANCER GENE THERAPY
- MicroRNAs as Regulators of Cisplatin Resistance in Lung Cancer
- (2015) Ying Chen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The role of ABC transporters in ovarian cancer progression and chemoresistance
- (2015) M.P. Ween et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
- (2015) Scott N. Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Leukocytes: The Double-Edged Sword in Fibrosis
- (2015) Jakub Kryczka et al. MEDIATORS OF INFLAMMATION
- The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer
- (2015) Yu Fujita et al. MOLECULAR THERAPY
- Crosstalk between translesion synthesis, Fanconi anemia network, and homologous recombination repair pathways in interstrand DNA crosslink repair and development of chemoresistance
- (2015) Brittany Haynes et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- A set of NF-κB–regulated microRNAs induces acquired TRAIL resistance in Lung cancer
- (2015) Young-Jun Jeon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid
- (2015) Valentina Bizzarro et al. Oncotarget
- MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G1/S transition and apoptosis by targeting p21WAF1/CIP1
- (2014) H Wang et al. BRITISH JOURNAL OF CANCER
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- EGCG Enhances the Efficacy of Cisplatin by Downregulating hsa-miR-98-5p in NSCLC A549 Cells
- (2014) Dong-Hu Zhou et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- miR-17-5p Downregulation Contributes to Paclitaxel Resistance of Lung Cancer Cells through Altering Beclin1 Expression
- (2014) Abhisek Chatterjee et al. PLoS One
- miRNA 17 Family Regulates Cisplatin-Resistant and Metastasis by Targeting TGFbetaR2 in NSCLC
- (2014) Zeyong Jiang et al. PLoS One
- Regulation of DNA Pairing in Homologous Recombination
- (2014) J. M. Daley et al. Cold Spring Harbor Perspectives in Biology
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Fanconi Anemia Repair Pathway Dysfunction, a Potential Therapeutic Target in Lung Cancer
- (2014) Wenrui Duan et al. Frontiers in Oncology
- Concordant and Discordant Regulation of Target Genes by miR-31 and Its Isoforms
- (2013) Yu-Tzu Chan et al. PLoS One
- MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5
- (2012) Xiang-hua Liu et al. BMC CANCER
- Drug resistance and its significance for treatment decisions in non-small-cell lung cancer
- (2012) G.D. Goss et al. Current Oncology
- MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN
- (2012) Zhi-Li Liu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- En bloc transfer of polyubiquitin chains to PCNA in vitro is mediated by two different human E2–E3 pairs
- (2012) Yuji Masuda et al. NUCLEIC ACIDS RESEARCH
- Pol31 and Pol32 subunits of yeast DNA polymerase are also essential subunits of DNA polymerase
- (2012) R. E. Johnson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cisplatin resistance induced by decreased apoptotic activity in non-small-cell lung cancer cell lines
- (2011) Vildan B. Cetintas et al. CELL BIOLOGY INTERNATIONAL
- Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-small Cell Lung Cancer Cells
- (2011) Junjun Chen et al. CHEMISTRY & BIOLOGY
- miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222
- (2011) M Acunzo et al. ONCOGENE
- Involvement of CCR6/CCL20/IL-17 Axis in NSCLC Disease Progression
- (2011) Sophie Kirshberg et al. PLoS One
- The Fanconi anemia pathway and DNA interstrand cross-link repair
- (2011) Xiaoyu Su et al. Protein & Cell
- miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death
- (2010) L. Galluzzi et al. CANCER RESEARCH
- SnapShot: Homologous Recombination in DNA Double-Strand Break Repair
- (2010) Gerard Mazón et al. CELL
- Translesion DNA synthesis polymerases in DNA interstrand crosslink repair
- (2010) The Vinh Ho et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Suppression of Rev3, the catalytic subunit of Pol , sensitizes drug-resistant lung tumors to chemotherapy
- (2010) J. Doles et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC
- (2009) E J Dean et al. BRITISH JOURNAL OF CANCER
- miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
- (2009) Michela Garofalo et al. CANCER CELL
- Polymerase mRNA Expression Predicts Survival of Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
- (2009) P. Ceppi et al. CLINICAL CANCER RESEARCH
- Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma
- (2009) Krepela INTERNATIONAL JOURNAL OF ONCOLOGY
- Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin
- (2008) Kyunghee Burkitt et al. Molecular Cancer
- Polyubiquitination of proliferating cell nuclear antigen by HLTF and SHPRH prevents genomic instability from stalled replication forks
- (2008) A. Motegi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now